These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20011040)

  • 21. Update on Creutzfeldt-Jakob disease.
    Mallucci G; Collinge J
    Curr Opin Neurol; 2004 Dec; 17(6):641-7. PubMed ID: 15542971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I; Cardinale A; Mattei S; Biocca S
    J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.
    Bate C; Tayebi M; Salmona M; Diomede L; Williams A
    Neurotox Res; 2010 Apr; 17(3):203-14. PubMed ID: 19644728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
    Pagadala NS; Bjorndahl TC; Joyce M; Wishart DS; Syed K; Landi A
    Bioorg Med Chem; 2017 Oct; 25(20):5875-5888. PubMed ID: 28951092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.
    Lewis PA; Properzi F; Prodromidou K; Clarke AR; Collinge J; Jackson GS
    Biochem J; 2006 Apr; 395(2):443-8. PubMed ID: 16441239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
    Baron GS; Caughey B
    J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
    Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
    J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation.
    Lee KJ; Panzera A; Rogawski D; Greene LE; Eisenberg E
    J Cell Sci; 2007 Aug; 120(Pt 15):2663-71. PubMed ID: 17635996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
    Kumar R; McClain D; Young R; Carlson GA
    J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
    Radford HE; Mallucci GR
    Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
    Bate C; Tayebi M; Williams A
    Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface.
    Hackl S; Ng XW; Lu D; Wohland T; Becker CFW
    J Biol Chem; 2021; 296():100359. PubMed ID: 33539927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.